vinflunine,docetaxel,erdafitinib,pembrolizumab
pierre fabre,merck,janssen
['urothelial', 'thor study', 'janssen']
for us #hcps at #asco23, watch dr. yohann loriot ( ) present efficacy &amp; safety results from the phase 3 thor study of patients with advanced or metastatic #urothelialcarcinoma with select fibroblast growth factor alterations. 
Dedicated to sharing Janssen Oncology scientific communications for US HCPs. Account run by Janssen Global Services LLC. Review our Guidelines: https://t.co/uieWByQjn3.